Stability aspects of salmon calcitonin entrapped in poly(ether-ester) sustained release systems

International Journal of Pharmaceutics

Volumn 248, Issue 1-2, 2002, Pages 229-237

  Van Dijkhuizen Radersma, R ^a   Nicolas, H M ^a   Blom, M ^a   De Groot, K ^a   Bezemer, J M ^a   Van De Weert, M ^b  

^a IsoTis BV   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Aggregation; Calcitonin; Controlled release; Poly(ether ester); Stabilization

Indexed keywords

CALCITONIN; COPOLYMER; DODECYL SULFATE SODIUM; ESTER DERIVATIVE; METAL ION; POLY(ETHYLENE GLYCOL)TEREPHTHALATE; POLYBUTYLENE TEREPHTHALATE; POLYETHYLENE TEREPHTHALATE; SODIUM ION; UNCLASSIFIED DRUG; WATER OIL CREAM;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED DRUG RELEASE; DRUG RELEASE; EMULSION; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

ANIMALS; CALCITONIN; DELAYED-ACTION PREPARATIONS; DRUG STABILITY; POLYESTERS; POLYETHYLENE TEREPHTHALATES;

EID: 0037032442     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00458-1     Document Type: Article

References (34)

1. Arvinte T., Cudd A., Drake A.F. The structure and mechanism of formation of human calcitonin fibrils. J. Biol. Chem. 268:1993;6415-6422.
2. Arvinte, T., Cudd, A., Philips, J., 1997. Fibrillated calcitonin pharmaceutical compositions. US patent 5 593 962, 14 January.
3. Asano M., Yoshida M., Omichi H., Mashimo T., Okabe K., Yuasa H., Yamanaka H., Morimoto S., Sakakibara H. Biodegradable poly(DL-lactic acid) formulations in a calcitonin delivery system. Biomaterials. 14:1993;797-799.
4. Baudyš M., Mix D., Kim S.W. Stabilization and intestinal absorption of human calcitonin. J. Control. Rel. 39:1996;145-151.
5. Baudyš, M., Kim, S.W., 1998. Stabilisation and oral delivery of calcitonin. US patent 5 726 154, 10 March.
6. Bauer H.H., Müller M., Goette J., Merkle H.P., Fringeli U.P. Interfacial adsorption and aggregation assosiated chages in secondary structure of human calcitonin monitored by ATR-FTIR spectroscopy. Biochemistry. 33:1994;12276-12282.
7. Bauer H.H., Aebi U., Häner M., Hermann R., Müller M., Merkle H.P. Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin. J. Struct. Biol. 115:1995;1-15.
8. Bezemer J.M., Radersma R., Grijpma D.W., Dijkstra P.J., Feijen J., Van Blitterswijk C.A. Zero-order release of lysozyme from poly(ethylene glycol)/poly(buthylene terephthalate) matrices. J. Control. Rel. 64:2000;179-192.
9. Boden S.D., Kaplan F.S. Calcium homeostasis. Orthopedic Clin. North Am. 21:1990;31-42.
10. Cholewinsky M., Lückel B., Horn H. Degradation pathways, analytical characterization and formulation strategies of a peptide and a protein Calcitonin and human growth hormone in comparison. Pharm. Acta Helv. 71:1996;405-419.
11. Cleland J.L., Jones A.J.S. Stable formulations of recombinant human growth hormone and interferon-γ for microencapsulation in biodegradable microspheres. Pharm. Res. 13:1996;1464-1475.
12. Cudd A., Arvinte T., Gaines Das R.E., Chinni C., MacIntyre I. Enhanced potency of human calcitonin when fibrillation is avoided. J. Pharm. Sci. 84:1995;717-719.
13. 125I-bovine calcitonin, in vitro-in vivo studies. J. Control. Rel. 59:1999;55-62.
14. Law S.L., Shih C.L. Characterization of calcitonin-containing liposome formulations for intranasal delivery. J. Microencap. 18:2001;211-221.
15. Lee K.C., Soltis E.E., Newman P.S., Buron K.W., Mehta R.C., DeLuca P.P. In vivo assessment of salmon calcitonin sustained release from biodegradable microspheres. J. Control. Rel. 17:1991;199-206.
16. Lee K.C., Lee Y.J., Song H.M., Chun C.J., DeLuca P.P. Degradation of synthetic salmon calcitonin in aqueous solution. Pharm. Res. 9:1992;1521-1523.
17. Lee Y.-H., Sinko P.J. Oral delivery of salmon calcitonin. Adv. Drug Deliv. Rev. 42:2000;225-238.
18. Millest A.J., Evans J.R., Young J.J., Johnstone D. Sustained release of salmon calcitonin in vivo from lactide:glycolide copolymer depots. Calcif. Tissue Int. 52:1993;361-364.
19. Morimoto K., Katsumata H., Yabuta T., Iwanaga K., Kakemi M., Tabata Y., Ikada Y. Evaluation of gelatin microspheres for nasal and intramuscular administrations of salmon calcitonin. Eur. J. Pharm. Sci. 13:2001;179-185.
20. Parfitt A.M. Bone and plasma calcium homeostasis. Bone. 8:1987;S1-S8.
21. Richardson, J.L., Miglietta, M., Ramires, P.A., Rochira, M., Fisher, A.N., Farraj, N.F., Illum, L., Benedetti, L.M., 1993. Vaginal administration of calcitonin in rats ans sheep using microspheres of hyaluronane esters. Proceedings of the International Symposium on Controlled Release Bioactive Material, 20.
22. Sakuma S., Ishida Y., Sudo R., Suzuki N., Kikuchi H., Hiwatari K., Kishida A., Akashi M., Hayashi M. Stabilization of salmon calcitonin by polystyrene nanoparticles having surface hydrophilic polymeric chains, against enzymatic degradation. Int. J. Pharm. 159:1997;181-189.
23. Stern, W., Gilligan, J.P., 1999. Oral salmon calcitonin pharmaceutical products. US patent 5 912 014, 15 June.
24. Stevenson C.L., Tan M.M. Solution stability of salmon calcitonin at high concentration for delivery in an implantable system. J. Peptide Res. 55:2000;129-139.
25. Susi H., Byler D.M. Protein structure by fourier transform infrared spectroscopy: second derivative spectra. Biochem. Biophys. Res. Commun. 115:1983;391-397.
26. Torres-Lugo M., Peppas N.A. Transmucosal delivery systems for calcitonin: a review. Biomaterials. 21:2000;1191-1196.
27. Vandamme, T.F., Gillard, J.L., 1993. Poly-ε-caprolactone microspheres containing calcitonin: Preparation, morphology and release properties. Proceedings of the International Symposium on Controlled Release and Bioactive Material, 20.
28. Van de Weert M., Van't Hof R., Van der Weerd J., Heeren R.M.A., Posthuma G., Hennink W.E., Crommelin D.J.A. Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques. J. Control. Rel. 68:2000;31-40.
29. Van de Weert M., Van Dijkhuizen-Radersma R., Bezemer J.M., Hennink W.E., Crommelin D.J.A. Reversible aggregation of lysozyme in a biodegradable amphiphilic multiblock copolymer. Eur. J. Pharm. Biopharm. 54:2002;89-93.
30. Van Dijkhuizen-Radersma R., Péters F.L.A.M.A., Stienstra N.A., Grijpma D.W., Feijen J., De Groot K., Bezemer J.M. Control of vitamin B12 from poly(ethylene glycol)/poly(buthylene terephthalate) multiblock copolymers. Biomaterials. 23:2002;1527-1536.
31. Veronesi, P.A., Peschechera, E., Veronesi, A.M., 2000. Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin. US patent 6 087 338, 11 July.
32. Wallach S., Rousseau G., Martin L., Azria M. Effects of calcitonin on animal and in vitro models of skeletal metabolism. Bone. 25:1999;509-516.
33. Yang T.-H., Dong A., Meyer J., Johnson O.L., Cleland J.L., Carpenter J.F. Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegradable microspheres. J. Pharm. Sci. 88:1999;161-165.
34. Zhu G., Mallery S.R., Schwendeman S.P. Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide). Nat. Biotechnol. 18:2000;52-56.